Onglyza is a pharmaceutical product. It is commonly used for Chronic Conditions. Available at affordable prices from MedsBase with worldwide shipping.

What are the side effects of Onglyza?

DPP-4 inhibitors are among the best-tolerated oral antidiabetics. Most side effects are mild and similar across the class. Common: Upper respiratory tract infection, nasopharyngitis Headache Mild GI upset — nausea, diarrhoea (less common than with metformin) Uncommon but important: Acute pa...

How can I order Onglyza online?

You can order Onglyza online from MedsBase with worldwide shipping. We supply WHO-GMP certified generic medications produced by licensed pharmaceutical manufacturers.

Onglyza

SKU: Onglyza Κατηγορία: Category Overview, Chronic Conditions, Diabetes, Diabetes Medication

✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026

Encrypted checkout

Crypto pays 10% less

Discreet worldwide delivery

1,400+ customers · 50+ countries

⚡ Quick Answer — What is Onglyza?

Onglyza is a brand of saxagliptin (2.5 mg or 5 mg), a DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor, also called a “gliptin”) used for type 2 diabetes. It works by blocking the enzyme DPP-4, which normally breaks down incretin hormones (GLP-1 and GIP). Higher incretin levels stimulate insulin release and suppress glucagon only when blood glucose is high — so DPP-4 inhibitors produce a glucose-dependent effect and do not cause hypoglycaemia as monotherapy. HbA1c reduction: 0.6–0.8 points. Weight-neutral. Once-daily dosing (most gliptins). First DPP-4 to complete a cardiovascular outcome trial (SAVOR-TIMI 53). Heart-failure signal means other DPP-4 inhibitors are usually preferred if HF is a concern. Cardiovascular-neutral for MACE in SAVOR-TIMI 53, but associated with a small increase in hospitalisation for heart failure. Use with caution in patients with existing heart failure. Dose: 5 mg once daily. Reduce to 2.5 mg/day if eGFR < 45 mL/min/1.73 m² or if co-prescribed with strong CYP3A4/5 inhibitors (ketoconazole, clarithromycin, ritonavir). Main side effects are mild — upper respiratory symptoms, headache, rare pancreatitis. Avoid in type 1 diabetes and DKA.

What you get with MedsBase: WHO-GMP certified manufacturer · Discreet packaging · Worldwide shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What Is Onglyza?

Onglyza is an oral antidiabetic medicine containing saxagliptin (2.5 mg or 5 mg), manufactured by AstraZeneca. Available in packs of 30, 60, 90 or 180 tablets. It is prescribed for adults with type 2 diabetes, usually alongside metformin or as a second- or third-line agent.

saxagliptin belongs to the DPP-4 inhibitor (“gliptin”) class — first approved 2009 (originator brand: Onglyza, AstraZeneca / Bristol-Myers Squibb). Gliptins are widely used because they are weight-neutral, have a low hypoglycaemia risk, and can be used across the renal spectrum with appropriate dose adjustment.

How Does Onglyza Work?

After meals, the gut releases two incretin hormones — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones tell the pancreas to release insulin and the liver to suppress glucagon, but they are rapidly broken down by the enzyme dipeptidyl peptidase-4 (DPP-4) within minutes.

saxagliptin blocks DPP-4. This raises active GLP-1 and GIP levels, producing:

Glucose-dependent insulin release from pancreatic beta cells — only when blood glucose is elevated
Suppression of glucagon from alpha cells, reducing hepatic glucose output after meals
Modest slowing of gastric emptying

Because insulin release is glucose-dependent, DPP-4 inhibitors do not cause hypoglycaemia on their own. Typical HbA1c reduction: 0.6–0.8 percentage points. Weight effect: neutral. Blood pressure and lipid effects: neutral.

Dosage and Administration

Standard dose: 5 mg once daily. Reduce to 2.5 mg/day if eGFR < 45 mL/min/1.73 m² or if co-prescribed with strong CYP3A4/5 inhibitors (ketoconazole, clarithromycin, ritonavir). Onglyza can be taken with or without food.

Once-daily dosing (twice for vildagliptin) — pick a consistent time.
Half-life and excretion: 2.5 hours (parent); 3 hours (active metabolite). Mixed hepatic and renal clearance..
Renal dosing: Full 5 mg dose if eGFR > 45; halve to 2.5 mg if eGFR 15–45 or on dialysis.
No hepatic dose adjustment for most gliptins (vildagliptin needs baseline ALT check).
Miss a dose — skip it; take the next at the usual time. Do not double up.

Side Effects

DPP-4 inhibitors are among the best-tolerated oral antidiabetics. Most side effects are mild and similar across the class.

Common:

Upper respiratory tract infection, nasopharyngitis
Headache
Mild GI upset — nausea, diarrhoea (less common than with metformin)

Uncommon but important:

Acute pancreatitis — rare but documented class effect; stop immediately if severe abdominal pain develops
Severe joint pain (arthralgia) — can occur weeks to months after starting; usually resolves on discontinuation
Hypersensitivity / angioedema — bullous pemphigoid has been reported; stop if blistering skin lesions develop
Saxagliptin specifically: small increase in hospitalisation for heart failure
Vildagliptin specifically: rare hepatic enzyme elevations — monitor ALT

As monotherapy, hypoglycaemia is very rare. When combined with sulfonylureas or insulin, those agents’ doses may need reducing.

Drug Interactions

Sulfonylureas, insulin, meglitinides — additive glucose-lowering. Expect to reduce these doses when adding a gliptin.
Strong CYP3A4/5 inhibitors (ketoconazole, clarithromycin, ritonavir, atazanavir) — raise saxagliptin levels; halve the saxagliptin dose. Minimal effect on sitagliptin, linagliptin, vildagliptin.
Rifampicin — reduces linagliptin levels modestly; effect may be clinically meaningful.
ACE inhibitors — theoretical additive angioedema risk; clinical significance debated.
Digoxin — small rise in peak level with sitagliptin; usually not clinically important.

Who Should Not Take Onglyza?

Type 1 diabetes mellitus
Diabetic ketoacidosis
Known hypersensitivity to saxagliptin or other DPP-4 inhibitors
History of pancreatitis (relative — discuss alternatives)
Pregnancy and breastfeeding — data limited; alternatives preferred
Saxagliptin specifically: severe heart failure
Vildagliptin specifically: ALT or AST > 3× upper limit of normal

Storage

Store Onglyza below 30°C in a dry place, in the original blister. Keep out of reach of children.

Frequently Asked Questions

Is Onglyza the same as saxagliptin?

Yes. Onglyza contains the same active ingredient as the originator brand. Bioequivalence is required by regulatory authorities, so clinical effect is the same at the same dose.

Does saxagliptin cause heart failure?

The SAVOR-TIMI 53 trial found a 27% relative increase in hospitalisation for heart failure with saxagliptin versus placebo (3.5% vs 2.8% over 2 years). MACE was neutral. Most guidelines advise avoiding saxagliptin in patients with established heart failure and preferring sitagliptin or linagliptin in that setting.

Will Onglyza cause low blood sugar?

On its own, no. DPP-4 inhibitors act in a glucose-dependent manner — they only augment insulin release when blood glucose is high. Hypoglycaemia only becomes a concern when Onglyza is combined with a sulfonylurea, meglitinide, or insulin.

Does Onglyza cause weight gain?

No — DPP-4 inhibitors are weight-neutral. This is one of the main reasons they are preferred over sulfonylureas in overweight patients.

Can Onglyza cause pancreatitis?

Acute pancreatitis is a rare but documented class effect. The absolute risk is small, and large trials (TECOS, CARMELINA, SAVOR) have generally shown no statistically significant excess. Stop immediately and seek medical attention if severe abdominal pain develops — especially pain radiating to the back.

How long does Onglyza take to work?

Fasting glucose starts to fall in the first week. Maximal HbA1c effect is at 12 weeks. If HbA1c has not fallen by at least 0.3–0.5% after 3 months, a different second agent (SGLT-2 inhibitor or GLP-1 agonist) should be considered.

Can I stop Onglyza suddenly if I don’t feel well?

Yes — DPP-4 inhibitors can be stopped abruptly without rebound hyperglycaemia. If you develop severe abdominal pain, skin blistering, or severe joint pain, stop and contact your doctor.

Where can I buy Onglyza online?

You can order Onglyza (2.5 mg or 5 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.

Related Diabetes Medications

⚕ Medical Disclaimer. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. DPP-4 inhibitors are associated with rare pancreatitis, severe joint pain, and bullous pemphigoid — always use under medical guidance and stop with prompt review if these occur.